These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20919951)

  • 1. Bioactive porous beads as an injectable urethral bulking agent: their in vitro evaluation on smooth muscle cell differentiation.
    Oh SH; Kim IG; Lee JY; Lee JY; Lee JH
    Tissue Eng Part A; 2011 Mar; 17(5-6):655-64. PubMed ID: 20919951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive porous beads as an injectable urethral bulking agent: in vivo animal study for the treatment of urinary incontinence.
    Kim IG; Oh SH; Lee JY; Lee JY; Lee JH
    Tissue Eng Part A; 2011 Jun; 17(11-12):1527-35. PubMed ID: 21275847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional recovery of urethra by plasmid DNA-loaded injectable agent for the treatment of urinary incontinence.
    Choi SJ; Oh SH; Kim IG; Chun SY; Lee JY; Lee JH
    Biomaterials; 2013 Jul; 34(20):4766-76. PubMed ID: 23545290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidic production of bioactive fibrin micro-beads embedded in crosslinked collagen used as an injectable bulking agent for urinary incontinence treatment.
    Vardar E; Larsson HM; Allazetta S; Engelhardt EM; Pinnagoda K; Vythilingam G; Hubbell JA; Lutolf MP; Frey P
    Acta Biomater; 2018 Feb; 67():156-166. PubMed ID: 29197579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual growth factor-loaded in situ gel-forming bulking agent: passive and bioactive effects for the treatment of urinary incontinence.
    Oh SH; Bae JW; Kang JG; Kim IG; Son JY; Lee JY; Park KD; Lee JH
    J Mater Sci Mater Med; 2015 Jan; 26(1):5365. PubMed ID: 25578713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel fabrication of PCL porous beads for use as an injectable cell carrier system.
    Lim SM; Lee HJ; Oh SH; Kim JM; Lee JH
    J Biomed Mater Res B Appl Biomater; 2009 Aug; 90(2):521-30. PubMed ID: 19145632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creating growth factor gradients in three dimensional porous matrix by centrifugation and surface immobilization.
    Oh SH; Kim TH; Lee JH
    Biomaterials; 2011 Nov; 32(32):8254-60. PubMed ID: 21798593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic proteins-immobilized polydioxanone porous particles as an artificial bone graft.
    Kim TH; Oh SH; Chun SY; Lee JH
    J Biomed Mater Res A; 2014 May; 102(5):1264-74. PubMed ID: 23703875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual growth factor-immobilized microspheres for tissue reinnervation: in vitro and preliminary in vivo studies.
    Kim TH; Oh SH; An DB; Lee JY; Lee JH
    J Biomater Sci Polym Ed; 2015; 26(5):322-37. PubMed ID: 25597228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells.
    Wang C; Cen L; Yin S; Liu Q; Liu W; Cao Y; Cui L
    Biomaterials; 2010 Feb; 31(4):621-30. PubMed ID: 19819545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual growth factor-immobilized bioactive injection material for enhanced treatment of glottal insufficiency.
    Choi YH; Ahn HJ; Park MR; Han MJ; Lee JH; Kwon SK
    Acta Biomater; 2019 Mar; 86():269-279. PubMed ID: 30599245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and long-term (2-year follow-up) in vivo osteogenic activities of human periosteum-derived osteoblasts seeded into growth factor-releasing polycaprolactone/pluronic F127 beads scaffolds.
    Lee JH; Woo DK; Kim TH; Kang JG; Yun JW; Park JH; Park BW; Kang YH; Rho GJ; Jang SJ; Park JS; Lee HC; Yoon YM; Hwang TS; Kim DR; Hwang SC; Lee DH; Kim HY; Oh SH; Byun JH
    J Biomed Mater Res A; 2017 Feb; 105(2):363-376. PubMed ID: 27643840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porous membrane with reverse gradients of PDGF-BB and BMP-2 for tendon-to-bone repair: in vitro evaluation on adipose-derived stem cell differentiation.
    Min HK; Oh SH; Lee JM; Im GI; Lee JH
    Acta Biomater; 2014 Mar; 10(3):1272-9. PubMed ID: 24370639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periurethral injection of sustained release basic fibroblast growth factor improves sphincteric contractility of the rat urethra denervated by botulinum-a toxin.
    Takahashi S; Chen Q; Ogushi T; Fujimura T; Kumagai J; Matsumoto S; Hijikata S; Tabata Y; Kitamura T
    J Urol; 2006 Aug; 176(2):819-23. PubMed ID: 16813954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondrogenesis using mesenchymal stem cells and PCL scaffolds.
    Kim HJ; Lee JH; Im GI
    J Biomed Mater Res A; 2010 Feb; 92(2):659-66. PubMed ID: 19235210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights to vascular smooth muscle cell and pericyte differentiation of mouse embryonic stem cells in vitro.
    Lindskog H; Athley E; Larsson E; Lundin S; Hellström M; Lindahl P
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1457-64. PubMed ID: 16627807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage.
    Narita Y; Yamawaki A; Kagami H; Ueda M; Ueda Y
    Cell Tissue Res; 2008 Sep; 333(3):449-59. PubMed ID: 18607632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of adipose-derived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta1 and bone morphogenetic protein-4.
    Wang C; Yin S; Cen L; Liu Q; Liu W; Cao Y; Cui L
    Tissue Eng Part A; 2010 Apr; 16(4):1201-13. PubMed ID: 19895205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of TGF-β1-conjugated biodegradable pluronic F127 hydrogel and its application with adipose-derived stem cells.
    Jung HH; Park K; Han DK
    J Control Release; 2010 Oct; 147(1):84-91. PubMed ID: 20599451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue engineered bulking agent with adipose-derived stem cells and silk fibroin microspheres for the treatment of intrinsic urethral sphincter deficiency.
    Shi LB; Cai HX; Chen LK; Wu Y; Zhu SA; Gong XN; Xia YX; Ouyang HW; Zou XH
    Biomaterials; 2014 Feb; 35(5):1519-30. PubMed ID: 24275524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.